|
|
||||||||
1 Zinpro Corporation, Eden Prairie, MN 55374
2 Balchem Corporation, Slate Hill, NY 10973
3 Bloomington, MN 55437
4 Department of Animal and Nutritional Sciences, University of New Hampshire, Durham 03824
5 AgriMedia Communications, Atlanta, GA 30324
6 Adisseo, Commentry, France
Corresponding author: Mike Socha; e-mail: msocha{at}zinpro.com.
| ABSTRACT |
|---|
|
|
|---|
Key Words: rumen-protected amino acids lysine methionine lactating cow
Abbreviation key: ECM = energy-corrected milk, MP = metabolizable protein, RPAA = rumen-protected AA, RPMet = rumen-protected Met, RPMet+Lys = rumen-protected Met plus Lys, 16B = 16.0% CP basal diet, 16M = 16.0% CP diet with 10.5 g of Met from rumen-protected Met, 16ML = 16.0% CP diet with 10.2 g of Met and 16.0 g of Lys from rumen-protected Met and rumen-protected Met plus Lys, 18.5B = 18.5% CP basal diet, 18.5M = 18.5% CP diet with 10.5 g of Met from rumen-protected Met, 18.5ML = 18.5% CP diet with 10.2 g of Met and 16.0 g of Lys from rumen-protected Met and rumen-protected Met plus Lys.
| INTRODUCTION |
|---|
|
|
|---|
The advantage of improving the balance of absorbable AA is the increased efficiency of use of absorbed AA for milk protein production. It has been demonstrated that improved Lys and Met nutrition reduced the amount of dietary CP needed to achieve similar yields of milk protein (Robert et al., 1989; Rulquin et al., 1990).
In most of the studies referred to above, a Latin Square with short experimental periods (generally 2 wk or less) was used as the experimental design, and in only a few experiments (Overton et al., 1996; Carson et al., 1998; Xu et al., 1998) did cows receive supplemental AA before or immediately after calving. The objectives of this study were: 1) to determine the effects of supplementing corn-based diets of prepartum and early postpartum cows with rumen-protected Met (RPMet) and rumen-protected Met plus Lys (RPMet+Lys) on early lactation performance, 2) to determine if the use of high-Lys protein supplements provided adequate intestinal supplies of Lys, and 3) to determine the effect of postpartum dietary CP on response to rumen-protected AA (RPAA) supplementation.
| MATERIALS AND METHODS |
|---|
|
|
|---|
|
Measurements, Collection, and Analysis of Samples
Feed ingredients and orts were sampled weekly, analyzed for DM (60°C under 760 mm of vacuum for 24 h), ground to pass through a 1-mm screen, and then composited across experiment by treatment. The orts were composited by treatment and analyzed for CP, NDF, ADF, ether extract, Ca, P, K, Mg, and S (Dairy One Forage Laboratory, Ithaca, NY). Composited samples of feed ingredients and orts were analyzed for AA concentrations using procedures described by Putnam et al. (1997). Composited samples of blood meal and expeller soybean meal were analyzed for RUP digestibility at the University of Minnesota using the 3-step procedure of Calsamiglia and Stern (1995).
Milk weights were recorded twice daily; milk samples were taken from 2 consecutive milkings each week. Milk samples were preserved with 2-bromo-2-nitropropane-1,3 diol and analyzed for fat and true protein by Dairy One Forage Laboratory (Ithaca, NY) using infrared technology. Body condition scores were obtained weekly by 3 individuals and averaged. Cows in blocks 1 through 12 were weighed daily. Body weights for the complete duration of the study were not available for cows in blocks 13 and 14, due to mechanical failure of the scale.
Blood samples were obtained by venipuncture of the coccygeal vein at approximately 2 h after the morning feeding during wk 1, 2, 3, 4, and 8 of lactation. Blood was collected into one 10-mL evacuated tube containing no additive and one 10-mL evacuated tube containing sodium heparin and 4% sodium fluoride (Vacutainer, Becton Dickinson, Rutherford, NJ). Tubes containing the anticoagulant were placed in an ice bath until centrifuged at 3300 x g for 20 min at 5°C. One aliquot of plasma was removed and frozen (20°C) for determination of glucose (Sigma kit Trinder 500, Sigma Chemical Co., St. Louis, MO) (Barham and Trinder, 1972) and NEFA (WAKO NEFA C kit, WAKO Chemicals USA, Inc., Richmond, VA) (Johnson and Peters, 1993) concentrations. An additional aliquot was deproteinized; 4 volumes were vortexed with 1 volume of 15% sulfosalicylic acid, centrifuged at 3300 x g for 20 min at 5°C, and the supernatant frozen (20°C) for BHBA analysis (Gibbard and Watkins, 1968). Blood in tubes containing no additive was allowed to clot at room temperature (15 to 21°C), centrifuged (3300 x g for 20 min), and the serum was frozen for determination of urea concentrations (Sigma kit 640, Sigma Chemical Co.) (Crocker, 1967). All plasma and serum samples were thawed at 5°C before analysis.
Statistical Analysis and Calculations
Production data were analyzed using the MIXED procedure of SAS (SAS Institute, 1999) according to the following model:
![]() |
where Yijkl is the dependent, continuous variable, µ is the overall mean, Ai is the fixed effect of the ith level of AA (i = 1,..., 3), Pj is the fixed effect of the jth level of protein (j = 1,2), ß is the regression coefficient, Xijk is the covariate measurement, ckij is the random effect of the kth cow with the ijth treatment subclass (k = 1,..., 14), Tl is the fixed effect of the lth week of experiment (l = 1,..., 15), Eijkl is the residual error, and APij, ATil, PTjl, and APTijl are fixed effects due to the interactions of the main effects.
In this model, the random effect of cows within treatment subclasses is used as the error term for the effect of AA and protein levels and their interactions. Residual errors, which are errors within cows across time and represent errors from repeated measurements from the experimental units (cows), were modeled using a first-order autoregressive covariance structure. Degrees of freedom were calculated using the Kenward-Roger option of the MIXED procedure (SAS Institute, 1999). A covariate term was included in the model to reduce the variance due to cow within treatment subclasses. The covariate variables were taken from the prior lactation of each cow and consisted of mature equivalents for milk production, milk component yields, or milk composition, as appropriate. The cows had not been assigned to an experiment in their previous lactation. Mature equivalent milk production was used as the covariate for DMI analysis. The covariate term was removed from the final statistical model in the analysis of BW, blood, and prepartum DMI data because analyzing the data without covariates resulted in smaller Bayesian information criteria values. Block effect was initially included in the model but was removed in the final analysis because it was found to be insignificant. Least square means were determined for AA source, protein level, and the interaction between AA source and protein level. The DIFF option in SAS was used to test treatment differences among least square means. Significant treatment responses were declared at P
0.05 and trends for treatment responses were declared at P > 0.05 but P
0.15.
The Univariate Procedure of SAS (SAS Institute, 1999) was used to determine outlier cows for DM intake during the prepartum period. An observation that was greater than 2.5 standard deviations (SD = 2.97) from the mean (mean = 14.66) for the last 7 d of gestation was considered an outlier. The results of the outlier analysis indicated that 2 cows were outliers due to extremely low (5.7 kg/d) and extremely high (25.1 kg/d) DMI; therefore these cows were removed from the final statistical analysis.
| RESULTS |
|---|
|
|
|---|
Chemical Composition of Ingredients and Diets
The chemical and AA compositions of feed ingredients are shown in Tables 2
and 3
. The measured RUP digestibility coefficients for expeller soybean meal and blood meal were 92.8 and 60.7%, respectively.
|
|
|
|
DMI and Lactation Responses
There was no effect of treatment (P > 0.15) on prepartum DMI (Table 5
). Cows receiving RPMet tended to (P
0.15) consume less DM than cows receiving no RPAA or RPMet+Lys (22.9 vs. 23.7 and 24.3 kg/d, respectively, Table 5
). Supplementing the basal diets with RPMet numerically reduced (P > 0.15) milk yield, whereas supplementing with RPMet+Lys numerically increased milk yield; the net result was that cows fed RPMet+Lys produced more (P
0.05) milk than cows fed RPMet (44.9 vs. 41.8 kg/d). Improving intestinal supply of Lys and Met through feeding RPMet+Lys compared with no RPAA or RPMet supplementation increased (P
0.05) yields of energy corrected milk (ECM; 45.9 vs. 43.6 and 43.0 kg/d), true protein (1306 vs. 1221 and 1218 g/d), and fat (1632 vs. 1550 and 1543 g/d; Table 5
). There was a trend (P
0.15) for cows fed RPMet+Lys to have higher yields of 3.5% FCM than cows fed the basal diets or the basal diets supplemented with RPMet (45.9 vs. 43.8 and 43.1 kg/d).
There was no effect (P > 0.15) of dietary CP on yield of DMI, milk, ECM, FCM, and fat. Increases in yield of milk true protein in response to dietary CP content were dependent on week postpartum (CP x week interaction, P
0.05; Figure 1
). Cows fed the 16% CP diets produced more milk protein in the weeks immediately after calving and as cows entered midlactation, whereas cows fed the 18.5% CP diets produced more milk protein when cows were at peak production.
|
0.05) percentage of true protein in milk (2.96 and 2.94 vs. 2.85) (Table 5
0.05). Supplementing 18.5B with RPMet and RPMet+Lys increased (P
0.05) milk true protein content 0.21 and 0.14 percentage units, whereas supplementing 16.0B with RPMet and RPMet+Lys had no effect. Similarly, RPAA supplementation of the basal diets had an inconsistent effect on milk fat content (CP x AA interaction, P
0.05). Adding RPMet to 18.5B increased (P
0.05) milk fat content by 0.26 percentage units, but did not affect milk fat content when added to 16B.
The effect of dietary CP content on milk true protein and fat concentrations was dependent on stage of lactation (CP x wk interaction, P
0.05). Compared with cows fed the 18.5% CP diets, cows fed the 16.0% CP diets produced milk with a higher protein content immediately following calving and a similar or lower protein content thereafter (Figure 2
). Feeding the 16% CP diets increased milk fat content in the immediate postpartum period and lowered milk fat content during wk 3 and 4 of lactation (Figure 3
). Feeding the 18.5% CP diets increased milk fat content as cows entered midlactation (Figure 3
).
|
|
0.05). Cows fed 18.5B produced milk with the lowest milk fat content immediately following parturition and at peak production. Cows fed 18.5M produced milk with the highest fat content immediately following calving and as cows approached peak production, whereas cows fed 16M produced milk with the lowest fat content as cows approached peak and midlactation (Figure 4
|
0.15) the efficiency of conversion of DMI to ECM (1.93 and 1.94 vs. 1.87 kg of ECM/kg of DMI; Table 5
0.05) with RPMet and RPMet+Lys supplementation (0.33 and 0.34 vs. 0.32 kg of milk N/kg of feed N). However, responses tended to be inconsistent across dietary CP levels (AA x CP interaction, P
0.15), with efficiency of conversion of feed N to milk N tending to improve when RPMet and RPMet+Lys were added to the 18.5% CP diet, but not the 16% CP diet. Reducing dietary CP from 18.5 to 16.0% increased (P
0.05) efficiency of conversion of consumed N to milk N (0.31 to 0.35).
There were no effects (P > 0.15) of treatment on BW or BW changes (Table 6
). Cows receiving 18.5ML tended to have lower BCS (P
0.15) at wk 1 postpartum compared with cows receiving 18B, whereas 16ML cows tended to have higher BCS than 16B cows (AA x CP interaction, P
0.15). There was no effect (P > 0.15) of treatment on body condition at wk 15 postpartum.
|
0.15) than cows fed only the basal diet. Feeding RPMet reduced serum urea concentrations (P
0.05) compared with feeding no RPAA or feeding RPMet+Lys. Cows fed the 16.0% CP diets had lower serum urea concentrations (P
0.05) than cows fed the 18.5% CP diets (Table 7
|
0.05; Figure 5
|
0.05). Immediately following parturition, glucose concentrations decreased for cows receiving 16M, 16ML, 18.5B, and 18.5ML, and increased for cows receiving 18.5M (Figure 6
|
| DISCUSSION |
|---|
|
|
|---|
The larger than expected response in milk yield to the increased intestinal supplies of Lys and Met in this study may be attributed to the fact that the cows received supplemental AA before calving. In 3 other trials in which RPMet or RPMet+Lys were added to lactating dairy diets beginning before calving and continuing through early lactation, milk yield was increased by an average of 1.2 kg/d (Overton et al., 1996; Carson et al., 1998; Xu et al., 1998). In comparison, initiating RPMet, RPLys, or RPMet+Lys supplementation after parturition (wk 1 to 20 postpartum) increased milk yield an average of only 0.1 kg/d (Armentano et al., 1993; Wu et al., 1997; Bertrand et al., 1998; Robinson et al., 1998; Samuelson et al., 2001; Moore et al., 2003; Noftsger and St. Pierre, 2003). However, increases in milk protein yield in response to RPAA supplementation appeared to be less affected by the stage of lactation in which supplementation was initiated. In the above experiments, starting supplementation before calving increased milk protein yield an average of 82 g/d (an increase of 7.1%), whereas initiating AA supplementation after calving increased milk protein yield an average of 35 g/d (an increase of 3.1%).
This experiment revealed no significant interactions of dietary CP and AA supplementation for milk and milk component yields. However, milk and milk component yield responses to RPMet+Lys were numerically greater with the 18.5% CP diet than with the 16.0% CP diet (Table 5
). Greater responses to RPLys+Met supplementation of 18.5B could have occurred if feeding this diet resulted in Lys, Met, or both being more deficient than feeding 16.0B. However, this did not appear to be the case. The 2 basal diets were evaluated with the NRC (2001) model and predicted flows of MP-Lys and MP-Met were 172 and 44 g/d for 18.5B and 157 and 42 g/d for 16.0B when DMI was held constant at 23.6 kg/d (Table 4
). The higher predicted flows of MP-Lys and MP-Met for 18.5B resulted primarily because of higher predicted flows of MP (2745 vs. 2582 g/d). The predicted concentrations of Lys and Met in MP for the 2 basal diets were similar (6.3 and 1.6% for 18.5B; 6.1 and 1.6% for 16.0B) (Table 4
). These results are supported by observations in a companion experiment where the 2 basal diets were fed to early-lactation, primiparous Holstein cows that were fitted with ruminal and duodenal cannulas (Putnam et al., 1997). Measured concentrations of Lys and Met in total AA of duodenal digesta were 6.8 and 2.0% for both diets. Measured flows of total AA for 18.5B and 16.0B were 3420 and 3042 g/d, respectively. Intakes of DM for 18.5B and 16.0B were 18.3 and 18.1 kg/d, respectively.
The increase in milk protein yield with RPMet+Lys supplementation in this study is consistent with other results (Donkin et al., 1989; Chapoutot et al., 1992; Robinson et al., 1992; Armentano et al., 1993; Robinson et al., 1993). However, in contrast to the previous observations, the increased yield of milk protein in the current experiment occurred mainly because of an increase in milk production, rather than an increase in milk protein content.
Somewhat surprising was the fact that feeding RPMet alone did not increase yield of milk protein and increased content of milk protein only when added to 18.5B (Table 5
). It is concluded in NRC (2001) that the required concentrations of Lys and Met in MP for maximum content and yield of milk protein are 7.1 to 7.2 and 2.4%, respectively, when the NRC (2001) model is used to predict concentrations of AA in MP. If these required concentrations are correct, then the optimum Lys:Met ratio in MP is 3.0:1. However, the evaluation of 18.5B and 16.0B with NRC (2001) yielded Lys:Met ratios in MP of 3.9:1 (6.3:1.6) and 3.8:1 (6.1:1.6), respectively (Table 4
). In the companion study, Putnam et al. (1997) observed Lys:Met ratios in duodenal digesta of 3.5:1 for both of the basal diets. Predicted duodenal supplies of Lys and Met using a factorial model (CPM-Dairy, version 3.0; New Bolton Center, University of Pennsylvania, Kennett Square, PA) resulted in Lys:Met ratios of 3.4:1 and 3.3:1, respectively, for 18.5B and 16.0B. In all cases, it is concluded that Met was more limiting than Lys and that the cows should have responded to RPMet supplementation.
One factor that may have contributed to cows not responding with increased yield of milk protein to RPMet supplementation is that the digestibility of Lys in the RUP fraction of blood meal may have been less than the measured digestibility coefficient of 60.7% for RUP. Of concern is that the blood meal was exposed to excessive heat during processing. This possibility is supported by the observations that the measured RUP digestibility (60.7% of CP) and Lys content (7.70% of CP) of the ring-dried blood meal (Table 3
) are both less than the NRC (2001) default values of 80 and 8.98%, respectively. It is well documented that Lys is the most vulnerable of the essential amino acids to heat damage (Schwab, 1995). For example, increasing the amount of heat applied to cottonseed meal (Broderick and Craig, 1980; Craig and Broderick, 1981), soybean meal (Parsons et al., 1992), and whole soybeans (Faldet et al., 1992) has been shown to decrease Lys concentration and the availability of the remaining Lys. There was no attempt in this experiment to measure Lys digestibility in the blood meal. However, it is of interest to note that even if Lys digestibility in the RUP fraction of the blood meal was decreased to 30%, calculated flows of MP-Lys would be decreased by 6 g for 18.5B and 5 g for 16.0B, lowering the Lys:Met ratios in MP from 3.9:1 and 3.7:1 for the 2 basal diets to 3.8:1 and 3.6:1, respectively.
CP-Sparing Effect of RPAA
The third objective of this study was to assess the dietary CP-sparing effect of RPMet and RPMet+Lys. This was difficult to assess as CP only affected efficiency of conversion of dietary N to milk N and the only sig-nificant CP x AA effects were observed for milk fat and true protein content. However, cows receiving 16ML numerically consumed more DM (24.3 vs. 23.9 kg/d), produced more ECM (45.2 vs. 43.7 kg/d), and converted dietary N to milk N with a higher gross efficiency (35 vs. 29%) than cows receiving 18.5B (Table 5
). These results suggest that 16ML was similar, if not superior, in nutritive value to 18.5B.
Accurate assessment of the CP-sparing effects of RPMet and RPMet+Lys requires a number of diets with varying levels of CP, and more specifically, different levels of RUP rather than RDP. Thus, the treatments in this study did not lend themselves to effectively determining the CP-sparing effect of RPAA, as response to RPMet and RPMet+Lys was examined at only 2 dietary CP levels, and CP levels were increased from 16 to 18.5% CP by increasing the RDP fraction rather than the RUP fraction.
Effect of RPAA on Blood Energy Metabolites
There was no effect of RPAA supplementation on clinical ketosis and other postcalving metabolic disorders. This is consistent with the lack of an observed effect of RPAA supplementation on postpartum plasma NEFA and BHBA. Effect of RPAA supplementation on plasma glucose was dependent on week postpartum, with cows supplemented with RPMet+Lys having lower plasma glucose concentrations during wk 1 and 2 postpartum than cows fed the other diets. The lower plasma glucose concentrations may be reflective of the fact that the cows supplemented with RPMet+Lys produced more ECM; across the 2-wk period, the cows produced 2.8 kg/d more ECM than the other cows (42.2 vs. 39.4 kg) while consuming only 0.9 kg/d more DM (17.7 vs. 16.8 kg). For the last 13 wk of the 15-wk treatment period, the cows fed RPMet+Lys produced 2.5 kg/d more ECM than the other cows (46.4 vs. 43.9 kg) and consumed 1.0 kg/d more DM (25.3 vs. 24.3 kg). In previous research, plasma NEFA, glucose, and BHBA were not affected when lactating dairy cows were fed RPMet+Lys (Chow et al., 1990; Chapoutot et al., 1992; Xu et al., 1998).
In contrast, postruminal infusion of a basal amount of Lys and incremental amounts of Met resulted in a linear increase in plasma BHBA of cows entering the second 100 d of lactation (Socha, 1994), but had no effect on plasma BHBA of cows assigned to the treatments before 50 DIM (Pisulewski et al., 1996; Socha, 1994) or after 150 DIM (Socha, 1994). In these same infusion studies, increasing the intestinal supply of Met linearly reduced plasma NEFA concentrations when the cows were assigned to the studies before 50 DIM (Pisulewski et al., 1996; Socha, 1994) but not when they began receiving treatments as they approached 100 DIM or after 150 DIM (Socha, 1994). One potential reason why blood concentrations of energy metabolites such as NEFA, BHBA, and glucose are not affected by improved Lys and Met nutrition in production studies (Chow et al., 1990; Chapoutot et al., 1992; Xu et al., 1998) is that the effect may be transitory. In the production studies, the experimental periods were 21 d or longer, with blood samples usually being collected several weeks after initiation of treatments. This is in contrast to the infusion experiments where the length of experimental periods was 10 to 14 d and all blood samples were taken less than 2 wk after initiation of treatments (Socha, 1994; Pisulewski et al., 1996).
| CONCLUSIONS |
|---|
|
|
|---|
| ACKNOWLEDGEMENTS |
|---|
|
|
|---|
| FOOTNOTES |
|---|
This study was supported by NC-185 (currently NC-1009) Cooperative Regional Research Project, "Metabolic Relationships in Supply of Nutrients for Lactating Cows," and by a grant from Adisseo, Antony, France. ![]()
Received for publication February 18, 2004. Accepted for publication July 15, 2004.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. T. Socha, C. G. Schwab, D. E. Putnam, N. L. Whitehouse, B. D. Garthwaite, and G. A. Ducharme Extent of Methionine Limitation in Peak-, Early-, and Mid-Lactation Dairy Cows J Dairy Sci, May 1, 2008; 91(5): 1996 - 2010. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Broderick, M. J. Stevenson, R. A. Patton, N. E. Lobos, and J. J. Olmos Colmenero Effect of Supplementing Rumen-Protected Methionine on Production and Nitrogen Excretion in Lactating Dairy Cows J Dairy Sci, March 1, 2008; 91(3): 1092 - 1102. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Johnson-VanWieringen, J. H. Harrison, D. Davidson, M. L. Swift, M. A. G. von Keyserlingk, M. Vazquez-Anon, D. Wright, and W. Chalupa Effects of Rumen-Undegradable Protein Sources and Supplemental 2-Hydroxy-4-(Methylthio)-Butanoic Acid and Lysine{middle dot}HCl on Lactation Performance in Dairy Cows J Dairy Sci, November 1, 2007; 90(11): 5176 - 5188. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cho, T. R. Overton, C. G. Schwab, and L. W. Tauer Determining the Amount of Rumen-Protected Methionine Supplement That Corresponds to the Optimal Levels of Methionine in Metabolizable Protein for Maximizing Milk Protein Production and Profit on Dairy Farms J Dairy Sci, October 1, 2007; 90(10): 4908 - 4916. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Firkins, A. N. Hristov, M. B. Hall, G. A. Varga, and N. R. St-Pierre Integration of Ruminal Metabolism in Dairy Cattle J Dairy Sci, March 1, 2006; 89(e_suppl_1): E31 - E51. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP |